FROM Josh Sommer
Cancer and the Business of Medicine The annual meeting of the American Society of Clinical Oncology brings together the latest on cancer research and treatment. Patients and their families pray for news of a breakthrough. Businesses look for investments; entrepreneurs look for opportunities. Last week in Chicago, some 4000 studies were presented to 30,000 top experts — but one warned there's "a growing sense that our optimism needs to be tempered a bit." We hear from him and others about how financial conflicts, personal habits and occupational hazards impact inroads against the disease.
Cancer: Big Business and the Painstaking Search for a Cure Five years ago, cancer researchers were predicting "miracle treatments" — even vaccines -- based on the billions being spent on genetics. But the more they know, the more complicated cancer becomes, and even the American Cancer Society has tempered its optimism. Cancer victims, and members of Congress, are increasingly impatient with the slow pace of improvement. Are financial conflicts part of the problem? Given what’s known about personal habits like smoking, about occupational hazards and the environment, should more be spent on prevention?
Nuclear crisis on the Korean Peninsula slowly coming to a head North Korea did not conduct a nuclear test this weekend, but it did show apparent progress in developing a missile that that could strike the United States. The Trump Administration says it has lost its "strategic patience." We hear what that might -- or might not -- mean for North Korea, China and the prospects for diplomacy.
The flight bumping heard around 'round the world Recent video of a passenger forcibly removed from a United Airlines plane is a worst-case example of what's happened since consolidation into just four US-based carriers. Management seems to be tone-deaf to a decline in service — and even abuse — of passengers.